Which are the causes of Biotinidase Deficiency?

Biotinidase deficiency is a rare, inherited metabolic disorder caused by mutations in the BTD gene, which prevents the body from recycling the essential vitamin biotin. Without this vital enzyme, the body cannot effectively process proteins, fats, and carbohydrates, leading to a buildup of toxic metabolic byproducts that can cause neurological and cutaneous symptoms.

What causes Biotinidase deficiency at the genetic level?

Biotinidase deficiency is caused by pathogenic variants in the BTD gene located on chromosome 3p25. This gene provides instructions for producing the enzyme biotinidase, which acts like a biological "recycler." Normally, this enzyme releases free biotin from dietary proteins, allowing the body to reuse it. When the BTD gene is mutated, the enzyme is either missing or non-functional. Because this is an autosomal recessive condition, a child must inherit two copies of the mutated gene—one from each carrier parent—to develop the full clinical manifestation of biotinidase deficiency.

Are there environmental triggers for this condition?

There are no known environmental triggers or lifestyle factors that cause biotinidase deficiency. It is strictly a genetic metabolic disorder present from birth. While the underlying cause is fixed at conception, the severity of the symptoms can be influenced by the specific type of mutation a person carries, which determines the residual enzyme activity level:

• Profound deficiency: Less than 10% of normal enzyme activity.


• Partial deficiency: Between 10% and 30% of normal enzyme activity.

Is the etiology of Biotinidase deficiency fully understood?

The metabolic mechanism of biotinidase deficiency is well-understood by researchers. When the body cannot recycle biotin, it impairs carboxylase enzymes that depend on biotin to function. This disruption leads to the accumulation of organic acids in the blood and urine. Current research is focused on genotype-phenotype correlations, aiming to better predict clinical outcomes based on specific BTD gene mutations found in patients, including the 14 individuals currently sharing their experiences on DiseaseMaps.org.

Next steps

• Consult a metabolic specialist or clinical geneticist to interpret BTD genetic testing results.


• Ensure newborns are screened via state-mandated newborn screening programs, which are highly effective at detecting biotinidase deficiency early.


• Join the biotinidase deficiency community on DiseaseMaps.org to connect with others navigating this diagnosis.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Biotinidase deficiency overview.


• Orphanet: Rare disease database entry for Biotinidase deficiency (ORPHA:125).


• OMIM (Online Mendelian Inheritance in Man): BTD gene entry #609019.